Specific labeling of synaptic schwann cells reveals unique cellular and molecular features
dc.contributor.author | Castro, Ryan W. | en |
dc.contributor.author | Taetzsch, Thomas | en |
dc.contributor.author | Vaughan, Sydney K. | en |
dc.contributor.author | Godbe, Kerilyn | en |
dc.contributor.author | Chappell, John C. | en |
dc.contributor.author | Settlage, Robert E. | en |
dc.contributor.author | Valdez, Gregorio | en |
dc.contributor.department | Fralin Biomedical Research Institute | en |
dc.contributor.department | Advanced Research Computing | en |
dc.date.accessioned | 2020-07-31T13:43:48Z | en |
dc.date.available | 2020-07-31T13:43:48Z | en |
dc.date.issued | 2020-06-25 | en |
dc.description.abstract | Perisynaptic Schwann cells (PSCs) are specialized, non-myelinating, synaptic glia of the neuromuscular junction (NMJ), that participate in synapse development, function, maintenance, and repair. The study of PSCs has relied on an anatomy-based approach, as the identities of cell-specific PSC molecular markers have remained elusive. This limited approach has precluded our ability to isolate and genetically manipulate PSCs in a cell specific manner. We have identified neuron-glia antigen 2 (NG2) as a unique molecular marker of S100 beta+ PSCs in skeletal muscle. NG2 is expressed in Schwann cells already associated with the NMJ, indicating that it is a marker of differentiated PSCs. Using a newly generated transgenic mouse in which PSCs are specifically labeled, we show that PSCs have a unique molecular signature that includes genes known to play critical roles in PSCs and synapses. These findings will serve as a springboard for revealing drivers of PSC differentiation and function. | en |
dc.description.notes | National Institutes of Health R01AG055545 Gregorio Valdez; National Institutes of Health R56AG051501 Gregorio Valdez; National Institutes of Health R21NS106313 Gregorio Valdez; The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication. | en |
dc.description.sponsorship | National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01AG055545, R56AG051501, R21NS106313] | en |
dc.format.mimetype | application/pdf | en |
dc.identifier.doi | https://doi.org/10.7554/eLife.56935 | en |
dc.identifier.issn | 2050-084X | en |
dc.identifier.other | e56935 | en |
dc.identifier.pmid | 32584256 | en |
dc.identifier.uri | http://hdl.handle.net/10919/99458 | en |
dc.identifier.volume | 9 | en |
dc.language.iso | en | en |
dc.rights | Creative Commons Attribution 4.0 International | en |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | en |
dc.title | Specific labeling of synaptic schwann cells reveals unique cellular and molecular features | en |
dc.title.serial | eLife | en |
dc.type | Article - Refereed | en |
dc.type.dcmitype | Text | en |
dc.type.dcmitype | StillImage | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- elife-56935-v2.pdf
- Size:
- 4.75 MB
- Format:
- Adobe Portable Document Format
- Description: